Similar articles for PMID: 31965751

Year	Number of Results
1993	1
1998	1
1999	1
2000	3
2001	2
2002	1
2003	1
2004	5
2005	1
2007	4
2008	2
2009	5
2010	8
2011	12
2012	14
2013	14
2014	17
2015	19
2016	10
2017	14
2018	18
2019	13
2020	23
2021	13
2022	2
2023	1
2024	0

1

Race, tumor location, and disease progression among low-risk prostate cancer patients.

Mygatt JG, Cullen J, Streicher SA, Kuo HC, Chen Y, Young D, Gesztes W, Williams G, Conti G, Porter C, Stroup SP, Rice KR, Rosner IL, Burke A, Sesterhenn I. Mygatt JG, et al. Cancer Med. 2020 Mar;9(6):2235-2242. doi: 10.1002/cam4.2864. Epub 2020 Jan 21. Cancer Med. 2020. PMID: 31965751 Free PMC article.

2

Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.

Cullen J, Young D, Chen Y, Degon M, Farrell J, Sedarsky J, Baptiste W, Rosen P, Tolstikov V, Kiebish M, Kagan J, Srivastava S, Kuo HC, Moncur JT, Rosner IL, Narain N, Akmaev V, Petrovics G, Dobi A, McLeod DG, Srivastava S, Sesterhenn IA. Cullen J, et al. Eur Urol Focus. 2018 Dec;4(6):818-824. doi: 10.1016/j.euf.2017.02.016. Epub 2017 Mar 11. Eur Urol Focus. 2018. PMID: 28753864 Free PMC article.

3

Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.

Ritch CR, Morrison BF, Hruby G, Coard KC, Mayhew R, Aiken W, Benson MC, McKiernan JM. Ritch CR, et al. BJU Int. 2013 Apr;111(4 Pt B):E186-90. doi: 10.1111/j.1464-410X.2012.11540.x. Epub 2012 Oct 26. BJU Int. 2013. PMID: 23107067

4

SPINK1 expression is enriched in African American prostate cancer but is not associated with altered immune infiltration or oncologic outcomes post-prostatectomy.

Faisal FA, Kaur HB, Tosoian JJ, Tomlins SA, Schaeffer EM, Lotan TL. Faisal FA, et al. Prostate Cancer Prostatic Dis. 2019 Dec;22(4):552-559. doi: 10.1038/s41391-019-0139-0. Epub 2019 Mar 8. Prostate Cancer Prostatic Dis. 2019. PMID: 30850708

5

Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence.

Knipper S, Sadat-Khonsari M, Boehm K, Mandel P, Budäus L, Steuber T, Maurer T, Heinzer H, Schwarz R, Sauter G, Tilki D, Huland H, Graefen M. Knipper S, et al. Clin Genitourin Cancer. 2020 Apr;18(2):e112-e121. doi: 10.1016/j.clgc.2019.09.007. Epub 2019 Sep 26. Clin Genitourin Cancer. 2020. PMID: 31648965

6

Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.

Faisal FA, Sundi D, Cooper JL, Humphreys EB, Partin AW, Han M, Ross AE, Schaeffer EM. Faisal FA, et al. Urology. 2014 Dec;84(6):1434-41. doi: 10.1016/j.urology.2014.08.039. Urology. 2014. PMID: 25432835 Free PMC article.

7

Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.

Freedland SJ, Vidal AC, Howard LE, Terris MK, Cooperberg MR, Amling CL, Kane CJ, Aronson WJ; Shared Equal Access Regional Cancer Hospital (SEARCH) Database Study Group. Freedland SJ, et al. Cancer. 2017 Nov 1;123(21):4199-4206. doi: 10.1002/cncr.30834. Epub 2017 Jun 27. Cancer. 2017. PMID: 28654204 Free PMC article.

8

Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.

Gandaglia G, Ploussard G, Valerio M, Marra G, Moschini M, Martini A, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Afferi L, Rakauskas A, Gontero P, Mattei A, Montorsi F, Briganti A. Gandaglia G, et al. Eur Urol Oncol. 2020 Dec;3(6):739-747. doi: 10.1016/j.euo.2020.07.008. Epub 2020 Aug 23. Eur Urol Oncol. 2020. PMID: 32847747

9

Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.

Marcq G, Michelet A, Hannink G, Rizk J, Sauvain J, Villers A, Saffarini M, Rochat CH. Marcq G, et al. BMC Cancer. 2018 Dec 27;18(1):1291. doi: 10.1186/s12885-018-5229-1. BMC Cancer. 2018. PMID: 30587172 Free PMC article.

10

High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes.

Hempel Sullivan H, Heaphy CM, Kulac I, Cuka N, Lu J, Barber JR, De Marzo AM, Lotan TL, Joshu CE, Sfanos KS. Hempel Sullivan H, et al. Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):668-675. doi: 10.1158/1055-9965.EPI-19-0962. Epub 2020 Jan 13. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31932412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

156 results

Results by year